RB 106

structure given in first source

Also Known As:

N-(3-(4-hydroxyphenyl)-2-mercaptopropionyl)glycyl(5-(3-hydroxyphenyl))proline; RB-106

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Myocardial Ischemia (Ischemic Heart Diseases) 06/21/1996 - "RB 106, which is one of the most potent dual inhibitors described to date, could have interesting clinical applications in long term treatment of congestive heart failure and myocardial ischemia."
2.	Heart Failure 06/21/1996 - "RB 106, which is one of the most potent dual inhibitors described to date, could have interesting clinical applications in long term treatment of congestive heart failure and myocardial ischemia."